Bespoke Extracts (BSPK) Non-Current Debt (2021 - 2025)
Bespoke Extracts (BSPK) reported Non-Current Debt of $169000.0 for Q3 2025, up 25.19% on a YoY basis from $135000.0 in Q3 2024, and down 43.4% sequentially from $298573.0 in Q2 2025.
Bespoke Extracts (BSPK) Non-Current Debt (2021 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 4 years of Non-Current Debt data on file, last reported at $169000.0 in Q3 2025.
- For the quarter ending Q3 2025, Non-Current Debt rose 25.19% year-over-year to $169000.0; the trailing twelve-month figure through Sep 2025 stood at $169000.0 (up 25.19% YoY), and the FY2024 full-year result was $241351.0, down 71.59% from the prior year.
- Non-Current Debt eased to $169000.0 in Q3 2025, from $298573.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $849500.0 in Q2 2023 to a low of $534.0 in Q4 2021.
- A 4-year average of $478268.9 and a median of $298573.0 in 2025 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt slumped 84.11% in 2024 and grew 25.19% in 2025, its largest moves.
- Tracing BSPK's Non-Current Debt over 4 years: stood at $534.0 in 2021, then soared by 158982.4% to $849500.0 in 2023, then slumped by 71.59% to $241351.0 in 2024, then declined by 29.98% to $169000.0 in 2025.
- Business Quant data shows BSPK's Non-Current Debt at $169000.0 in Q3 2025, $298573.0 in Q2 2025, and $169000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 169,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 169,000.00 |
| Jun 30, 2025 | 298,573.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 241,351.00 |
| Sep 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 849,500.00 |
| Mar 31, 2024 | 849,500.00 |
| Dec 31, 2023 | 849,500.00 |
| Sep 30, 2023 | 849,500.00 |
| Jun 30, 2023 | 849,500.00 |
| Nov 30, 2021 | 534.00 |